Page 2 - Study Director News Today

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced two...

In this study we have 300 patients with 47 different diseases subject to 7 experimental treatments among 3 treatment groups and no control group. What could possibly go right?

Toronto, ON (PRWEB) November 03, 2021 -- The Extended One Generation Reproductive Toxicity Study (EOGRTS, EU B.56, OECD TG 443) has been the information

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) has extended its partnership agreement with REPROCELL to assess the effect of the HT-003 therapeutic...

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) has extended its partnership agreement with REPROCELL to assess the effect of the HT-003 therapeutic...

The Research Associate is responsible for executing formulations study activities to ensure quality and timely completion of  studies.  These include: •    Write procedures, i.e., Formulation Batch Records and Dispense definitions, for the preparation, aliquoting, and weigh outs of dosing formulations. •    Review protocols and make sure protocol requirements are met.   Calculate Test Article requirements based on protocols and study designs. •    Coordinate study activities w...

Researchers world-wide are focused on clearing the toxic mutant Huntingtin protein that leads to neuronal cell death and systemic dysfunction in Huntington's disease (HD), a devastating, incurable, progressive neurodegenerative genetic disorder.

Join three experts as they take your questions on emerging trends in food safety, the analytical challenges they face and where gas chromatography mass spectrometry is headed.

Believing in one’s own capabilities boosts personal resilience, shows study The unpredictable nature of life during the coronavirus pandemic is particularly challenging for many people. Not everyone can cope equally well with the uncertainty and loss of control. Research has shown that while a large segment of the population turns out to be resilient in times of stress and potentially traumatic events, others are less robust and develop stress-related illnesses. Events that some people experi...

5 Questions with Akunna Iheanacho, Ph.D., Scientific Director, Texcell North America, Inc. “5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little about themselves, their work, and maybe something completely unrelated. March is WOMEN’S HISTORY MONTH and BioBuzz will celebrate by featuring Women in the BioHealth industry all month, especially in “5 Questions With…”. This week we welcome Akunna Iheanac...